AlphAIAlphAI — Financial news for AI agents
stocktitan.netAUG 201 min read$CUZ

Cousins Properties (NYSE: CUZ) officer plans sale of compensation shares

Cousins Properties (NYSE: CUZ) officer Jeffrey D. Symes filed a notice to sell common stock under Rule 144. The shares, totaling 5,767, were acquired as compensation in 2024 and 2026. The filing does not confirm the sale has occurred or will occur.

Original reporting
stocktitan.net
Published Aug 20, 2026, 3:20 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Aug 20, 2026, 10:17 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
About AlphAI AI DeskScoring methodologyReport an issue
AlphAI market briefCorporate actions
Primary signal
$CUZ
Neutral
medium confidence
Mentioned
$CUZ
Relevance
5/10
AlphAI data visualization · based on stocktitan.net
Decision brief

The 30-second read

$CUZNeutralLow
01

Why it matters

The filing adds a modest supply risk for CUZ but does not indicate a large capital move.

02

Market read

A routine insider sale filing with limited immediate market impact.

03

What to watch

Timing of the actual sale and market conditions could amplify impact.

Relevance 5/10Novelty 6/10Timing: today

Background

Form 144 filings are required for insiders planning to sell restricted shares, providing transparency to the market.

Company-level read

Ticker impact

$CUZNeutralMedium confidence
Context

Officer Jeffrey D. Symes filed a Form 144 indicating intent to sell several thousand compensation shares.

Expected impact

Minor downward pressure if shares are sold in the near term.

Evidence & confidence

The filing is a primary disclosure but the share count is small relative to float.

Market effects

Sector

Minimal impact on REIT sector.

Regional

Limited to US REIT investors.

Global

Low

Counterpoint

What could challenge this read

The sale may signal insider confidence if shares are sold at a premium.

Key entities

  • Officer
    Jeffrey D. Symes

    Cousins Properties officer filing Form 144.

Read at source← All news

Related articles

JUL 31
$CUZMed

Cousins Properties: Q2 Earnings Snapshot

Cousins Properties (CUZ) reported Q2 funds from operations of $124.6 million, or 75 cents per share, beating a Zacks-surveyed analyst average of 74 cents. Net income was $26.2 million, or 16 cents per share. Revenue was $268.5 million. The company forecast full-year FFO of $2.92 to $2.98 per share.

local3news.com2 min
JUL 30
$CUZMed

COUSINS PROPERTIES INC (CUZ): Results of Operations and Financial Condition

COUSINS PROPERTIES INC (CUZ) filed an SEC Form 8-K — Results of Operations and Financial Condition. Cousins Properties 1 Q2 2026 Supplemental Information TABLE OF CONTENTS Forward-Looking Statements 2 Earnings Release 3 Company Information 5 Consolidated Balance Sheets 7 Consolidated Statements of Operations 8 Key Performance Metrics 9 Funds From Operations - Summary 12 Funds F

SEC EDGAR 8-K6 min
SEP 26
$CLWMed

Clearwater Paper (CLW) Refinances Debt Through 2031. Does More Time Mean a Stronger Balance Sheet?

Clearwater Paper (CLW) refinanced its debt, securing a $275M term loan and $200M revolving facility, both maturing in 2031. The funds were used to redeem $275M of notes due 2028. The new facilities have a higher initial interest rate of 8.25% compared to the old 4.75% coupon. The company's first-half operating cash flow improved to $69.5M, aided by insurance recoveries and tax refunds.

insidermonkey.com3 min
SEP 26
$TTEMed

TotalEnergies (TTE) Eyes a Bigger $16 Billion Bet on Iraq: Could this Unlock More Growth?

TotalEnergies (TTE) and Iraq's government are discussing energy projects, potentially increasing investments from $12B to $16B. CEO Patrick Pouyanne aims to boost Iraq's oil production, leveraging existing infrastructure like the $10B Gas Growth Integrated Project (GGIP). Projects could support TTE's 3% production growth target by 2026, but details and geopolitical risks remain unclear.

insidermonkey.com2 min
SEP 26
$VKTXHighAI 8/10

What Viking Therapeutics Stock Means For Shareholders After Obesity Drug Data And $500 Million Raise

Viking Therapeutics (VKTX) reported positive obesity drug data for VK2735 and raised $500M, including $275M in common stock and $225M in convertible notes. The funds support R&D and Phase 3 trials but introduce future dilution risks. Analysts project $118.5M revenue and $12.9M earnings by 2029, with some forecasting higher figures. The company has no revenue and reported a $358.5M loss in 2025.

simplywall.st2 min